World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
26584
World Ranking
15559
National Ranking
178

Tapani Ruutu publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Tapani Ruutu sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 351 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Tapani Ruutu D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Tapani Ruutu sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Tapani Ruutu is affiliated with the University of Helsinki in Finland and specializes in the field of Medicine, with a focus on Hematology and related subfields. Their research primarily addresses issues within hematopoietic stem cell transplantation and multiple myeloma, alongside several other hematological and oncological topics.

Their frequent coauthors include Rafael F. Duarte, Zinaida Perić, Mahmoud Aljurf, Mohamad Mohty, and Mutlu Arat, reflecting a collaborative research approach in the field.

Tapani Ruutu has contributed significantly to the following publication venues: Bone Marrow Transplantation, The Lancet Haematology, Annals of Hematology, Journal of Clinical Medicine, and Biology of Blood and Marrow Transplantation.

The main topics covered in their work are:

  • Hematopoietic Stem Cell Transplantation
  • Multiple Myeloma Research and Treatments
  • Polyomavirus and related diseases
  • Neutropenia and Cancer Infections
  • Blood disorders and treatments
  • Platelet Disorders and Treatments
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Notable recent papers include:

  • Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party study, 2023, Bone Marrow Transplantation
  • Long-term outcome after allogeneic stem cell transplantation in multiple myeloma, 2021, Annals of Hematology
  • Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT), 2023, Bone Marrow Transplantation
  • Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation, 2024, The Lancet Haematology
  • Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation, 2020, The Lancet Haematology

Best Publications

  • Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia

    Vanderson Rocha;Myriam Labopin;Guillermo Sanz;William Arcese

  • Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

    Jürgen Finke;Wolfgang A Bethge;Claudia Schmoor;Hellmut D Ottinger

  • Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation

    A. Gratwohl;J. Hermans;J. Goldman;W. Arcese

  • Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome.

    Jason A. Coppell;Paul G. Richardson;Robert Soiffer;Paul L. Martin

  • Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT).

    M. Aoudjhane;M. Labopin;N. C. Gorin;A. Shimoni

  • Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation

    M. Mohty;F. Malard;M. Abecassis;E. Aerts

  • Antilymphocyte globulin for prevention of chronic graft-versus-host disease

    Nicolaus Kröger;Carlos Solano;Christine Wolschke;Giuseppe Bandini

  • Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

    Olaf Penack;Monia Marchetti;Tapani Ruutu;Mahmoud Aljurf

  • Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party.

    Enric Carreras;Hartmut Bertz;William Arcese;Jean-Paul Vernant

  • Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.

    Rodrigo Martino;Simona Iacobelli;Ronald Brand;Thekla Jansen

  • Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy : results of a consensus process by an International Working Group

    Tapani Ruutu;Giovanni Barosi;Richard J. Benjamin;Richard E. Clark

  • Sinusoidal obstruction syndrome/veno-occlusive disease: Current situation and perspectives - A position statement from the European Society for Blood and Marrow Transplantation (EBMT)

    M. Mohty;F. Malard;M. Abecassis;E. Aerts

  • Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

    T. Ruutu;A. Gratwohl;T. De Witte;B. Afanasyev

  • Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.

    Gérard Socié;Claudia Schmoor;Wolfgang A. Bethge;Hellmut D. Ottinger

  • Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia

    ZiYi Lim;Ronald Brand;Rodrigo Martino;Anja van Biezen

  • Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients.

    E Jantunen;P Ruutu;L Niskanen;L Volin

  • Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies.

    Gérard Socié;Reginald A. Clift;Didier Blaise;Agnès Devergie

  • Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

    Alois Gratwohl;Ronald Brand;Jane Apperley;Charles Crawley

  • EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment.

    Helene M. Schoemans;Stephanie J. Lee;James L. Ferrara;Daniel Wolff

  • Treosulfan/fludarabine: a new conditioning regimen in allogeneic transplantation.

    J Casper;W Knauf;I Blau;T Ruutu

Frequent Co-Authors

Sakari Knuutila
Sakari Knuutila University of Helsinki
Dietger Niederwieser
Dietger Niederwieser Leipzig University
Alois Gratwohl
Alois Gratwohl University of Basel
Jane F. Apperley
Jane F. Apperley Imperial College London
Arnon Nagler
Arnon Nagler Sheba Medical Center
Nicolaus Kröger
Nicolaus Kröger Universität Hamburg
Theo de Witte
Theo de Witte Radboud University
Jürgen Finke
Jürgen Finke University of Freiburg
Vanderson Rocha
Vanderson Rocha Universidade de São Paulo
Marcelo L. Larramendy
Marcelo L. Larramendy National University of La Plata

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students considering a future in medicine, online degree options offer flexible and accessible ways to enter or advance in the healthcare field. Aspiring nurses can explore lpn online programs, which are designed for those looking to quickly start a nursing career without sacrificing quality education. These programs often feature accelerated coursework and flexible scheduling.

For those looking to pursue advanced practice roles, online dnp programs provide a pathway to the highest level of nursing practice. Some learners may benefit from easy dnp programs, which balance academic rigor with manageable workloads to support a variety of student needs.

Mental health is a growing area in healthcare, and the accelerated msn psychiatric np programs equip nurses to meet this demand efficiently. Overall, these diverse online pathways enable students to build rewarding healthcare careers and adapt to the evolving needs of patients.

Best Scientists Citing Tapani Ruutu

Trending Scientists

Recently Published Articles